Menu
Back to Journals » Biologics: Targets and Therapy » Volume 12
Review
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 30,948 | Dovepress* | 12,328+ | 1,845 | 14,173 | |
| PubMed Central* | 18,620 | 1,318 | 19,938 | ||
| Totals | 30,948 | 3,163 | 34,111 | ||
| *Since 18 January 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 9 | 0 | 0 | 0 | 3 | 6 |
View citations on PubMed Central and Google Scholar